Marc Siegel, MD

Associate Professor, Department of Medicine, School of Medicine and Health Services, The George Washington University
Phone: 202-741-2234
[email protected]

Current HIV/AIDS Research Activities

  Principle Investigator in several studies related to HIV

  • A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men
  • A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection among men and transgender persons who have sex with men
  • A Phase IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Investigational Injectable HIV Integrase Inhibitor, GSK1265744, in HIV-uninfected Men and Women.
  • Advancing Pre-exposure Prophylaxis (PrEP) Delivery among Black MSM in the District of Columbia.
  • The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in young MSM of color in Washington, DC

Current HIV/AIDs Educational Activities:

  • Teaching of fellows, residents and medical students during Infectious Disease rounds at GW Hospital

Current HIV/AIDS Clinical Activities:

  • Taking care of HIV-infected patients in the MFA outpatient clinic as well as in the inpatient setting at George Washington University Hospital